Press Releases
3 September 2019
PHOENIX, Sept. 3, 2019 /PRNewswire/ -- A Phoenix-based technology expert and a behavioral health advocate have launched a digital health management platform designed to promote positive and sustainable outcomes for patients while increasing revenues for providers.
Read more...BROOMFIELD, Colo., Sept. 3, 2019 /PRNewswire/ -- SCL Health continues to build on its commitment to person-centered care and transforming the patient experience through innovative and
Read more...3 September 2019
BETHESDA, Md., Sept. 3, 2019 /PRNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) announces that Maximilian Muenke, MD, FACMG will become its new CEO, following a thorough national search.
Read more...3 September 2019
SEATTLE, Sept. 3, 2019 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the last patient has been enrolled in "STOP-301" (Safety and Tol
Read more...3 September 2019
SANTA ANA, Calif., Sept. 3, 2019 /PRNewswire/ -- Kelly Williams of Fullerton, a direct support professional who was honored with a Regional Center
Read more...3 September 2019
KRAKOW, Poland, Sept. 3, 2019 /PRNewswire/ -- Selvita (WSE: SLV) a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that the Polish Financial Supervision Authority has approved the prospectus of Selvita CRO, a requ
Read more...3 September 2019
ALAMEDA, Calif., Sept. 3, 2019 /PRNewswire/ -- Magnetic Insight, Inc., the leader in magnetic particle imaging (MPI) solutions, introduces the first commercially available MPI system with integrated X-ray computed tomography (CT), offering anatomical context to the newest breakthrough molecular imaging modality. The platform debuts September 3
Read more...3 September 2019
PARIS and LAKE OSWEGO, Ore., Sept. 3, 2019 /PRNewswire/ -- BIOTRONIK's ultrathin Orsiro® stent demonstrated superiority over Xience with respect to target lesion failure (TLF) at 12 months, according to newly released data from the BIOSTEMI trial.1 Yesterday at the European Society of Cardiology 2019 Congress, Dr
Read more...3 September 2019
MANHASSET, N.Y., Sept. 3, 2019 /PRNewswire/ -- North Shore University Hospital announced that it has begun offering genital gender confirmation surgery for members of the tr
Read more...3 September 2019
KANSAS CITY, Mo., Sept. 3, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyund
Read more...